{"id":"https://openalex.org/W2014639431","doi":"https://doi.org/10.1046/j.1365-2893.2003.00402.x","title":"The safety and tolerability of daily infergen plus ribavirin in the treatment of na\u00ed\u00efve chronic hepatitis C patients","display_name":"The safety and tolerability of daily infergen plus ribavirin in the treatment of na\u00ed\u00efve chronic hepatitis C patients","publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W2014639431","doi":"https://doi.org/10.1046/j.1365-2893.2003.00402.x","mag":"2014639431","pmid":"https://pubmed.ncbi.nlm.nih.gov/12558913"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2893.2003.00402.x","doi":"https://doi.org/10.1046/j.1365-2893.2003.00402.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2893.2003.00402.x","pdf_url":null,"source":{"id":"https://openalex.org/S164225461","display_name":"Journal of Viral Hepatitis","issn_l":"1352-0504","issn":["1352-0504","1365-2893"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Viral Hepatitis","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058911085","display_name":"Paul J. Pockros","orcid":"https://orcid.org/0000-0001-9438-5893","observed_orcids":["https://orcid.org/0000-0001-9438-5893"]},"institutions":[{"id":"https://openalex.org/I4210146328","display_name":"Scripps Clinic","ror":"https://ror.org/05kwjwj05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1311914864","https://openalex.org/I4210146328"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"P. J. Pockros","raw_affiliation_strings":["Department of Gastroenterology, Scripps Clinic, La Jolla, CA 92037, USA. ppockros@scrippsclinic.com","Head, Departments of Gastroenterology & Hepatology, Scripps Clinic, La Jolla, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastroenterology, Scripps Clinic, La Jolla, CA 92037, USA. ppockros@scrippsclinic.com","institution_ids":["https://openalex.org/I4210146328"]},{"raw_affiliation_string":"Head, Departments of Gastroenterology & Hepatology, Scripps Clinic, La Jolla, CA,","institution_ids":["https://openalex.org/I4210146328"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028313899","display_name":"Robert Reindollar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Reindollar","raw_affiliation_strings":["Medical Director, Center for Liver Diseases, Charlotte, NC,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Director, Center for Liver Diseases, Charlotte, NC,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019408263","display_name":"John G. McHutchinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. McHutchinson","raw_affiliation_strings":["Associate Professor of Medicine, Director, GI/Hepatology Research, Duke Clinical Research Institute, Durham, NC,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Associate Professor of Medicine, Director, GI/Hepatology Research, Duke Clinical Research Institute, Durham, NC,","institution_ids":["https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039066540","display_name":"K. Rajender Reddy","orcid":"https://orcid.org/0000-0002-4898-7778","observed_orcids":["https://orcid.org/0000-0002-4898-7778"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Reddy","raw_affiliation_strings":["Professor of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Professor of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA,","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009050197","display_name":"Teresa Lyn Wright","orcid":"https://orcid.org/0000-0002-9174-9409","observed_orcids":["https://orcid.org/0000-0002-9174-9409"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Wright","raw_affiliation_strings":["Professor, Department of Medicine, University of California, San Francisco, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Professor, Department of Medicine, University of California, San Francisco, CA,","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054081801","display_name":"Donna Boyd","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D.G. Boyd","raw_affiliation_strings":["Clinical Trial Consultant, Durham, NC,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Trial Consultant, Durham, NC,","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033778988","display_name":"Linda B. Wilkes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L.B. Wilkes","raw_affiliation_strings":["Project Manger, SC Liver Research Consortium, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Project Manger, SC Liver Research Consortium, San Diego, CA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5058911085"],"corresponding_institution_ids":["https://openalex.org/I4210146328"],"apc_list":{"value":4610,"currency":"USD","value_usd":4610},"apc_paid":null,"fwci":2.1751,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.87617555,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"10","issue":"1","first_page":"55","last_page":"60"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11495","display_name":"Animal Virus Infections Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10276","display_name":"Helicobacter pylori-related gastroenterology studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.8489999771118164},{"id":"https://openalex.org/keywords/consensus-interferon","display_name":"consensus interferon","score":0.843999981880188},{"id":"https://openalex.org/keywords/interferon-alpha-2b","display_name":"interferon alfa-2b","score":0.9580000042915344},{"id":"https://openalex.org/keywords/ribavirin","display_name":"ribavirin","score":0.9929999709129333},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.718999981880188},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.42399999499320984},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.9279999732971191},{"id":"https://openalex.org/keywords/sustained-virologic-response","display_name":"sustained virological response","score":0.824999988079071},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.5849999785423279},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6050000190734863},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.5720000267028809},{"id":"https://openalex.org/keywords/genotype-1","display_name":"genotype 1","score":0.6029999852180481},{"id":"https://openalex.org/keywords/daily-dosing","display_name":"daily dosing","score":0.5839999914169312},{"id":"https://openalex.org/keywords/antiviral-therapy","display_name":"antiviral therapy","score":0.6299999952316284},{"id":"https://openalex.org/keywords/viral-load-reduction","display_name":"viral load reduction","score":0.6499999761581421},{"id":"https://openalex.org/keywords/hcv-rna-quantification","display_name":"HCV RNA quantification","score":0.4359999895095825},{"id":"https://openalex.org/keywords/hcv-genotyping","display_name":"HCV genotyping","score":0.5099999904632568}],"concepts":[{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.9077821969985962},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8966821432113647},{"id":"https://openalex.org/C3020491458","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Chronic hepatitis","level":3,"score":0.6468868255615234},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5887690782546997},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.5812703371047974},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43230000138282776},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3795427680015564},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35138800740242004},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.284446120262146},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.04989209771156311}],"mesh":[{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012449","descriptor_name":"Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1365-2893.2003.00402.x","doi":"https://doi.org/10.1046/j.1365-2893.2003.00402.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2893.2003.00402.x","pdf_url":null,"source":{"id":"https://openalex.org/S164225461","display_name":"Journal of Viral Hepatitis","issn_l":"1352-0504","issn":["1352-0504","1365-2893"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Viral Hepatitis","raw_type":"journal-article"},{"id":"pmid:12558913","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12558913","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of viral hepatitis","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W138424127","https://openalex.org/W1985882441","https://openalex.org/W2004565614","https://openalex.org/W2009798224","https://openalex.org/W2011707824","https://openalex.org/W2027545702","https://openalex.org/W2033142105","https://openalex.org/W2039441730","https://openalex.org/W2064551902","https://openalex.org/W2067953846","https://openalex.org/W2079377965","https://openalex.org/W2105965047","https://openalex.org/W2114223742","https://openalex.org/W2127685726","https://openalex.org/W2153072823","https://openalex.org/W2156574153","https://openalex.org/W2165715544","https://openalex.org/W2314619766","https://openalex.org/W2317554121","https://openalex.org/W2332630894","https://openalex.org/W2419441684","https://openalex.org/W2466165747"],"related_works":["https://openalex.org/W2317554121","https://openalex.org/W2358917688","https://openalex.org/W2131338154","https://openalex.org/W278629488","https://openalex.org/W38390419","https://openalex.org/W47800385","https://openalex.org/W2010622438","https://openalex.org/W2136332203","https://openalex.org/W2015724905","https://openalex.org/W1866344432"],"abstract_inverted_index":{"The":[0,121,144,222,330],"treatment":[1,67,79,112,281],"of":[2,12,37,56,68,102,119,146,173,203,224,272,285,302,312,322,328],"chronic":[3,69],"hepatitis":[4,70],"C":[5,71],"patients":[6,371],"was":[7,17,152,229,287],"enhanced":[8],"when":[9,41,372],"the":[10,35,52,65,110,141,159,176,212,248,297,303,360],"combination":[11,111,162,179,215,251,331],"interferon":[13,26,39],"alfa-2b":[14],"and":[15,22,54,134,155,161,168,178,201,214,232,244,250,266,299,357],"ribavirin":[16,60,91,356],"shown":[18],"to":[19,50,61,77,256,260,289,317],"be":[20,290,315,352],"safe":[21],"more":[23],"effective":[24],"than":[25,343],"monotherapy.":[27],"To":[28],"date,":[29],"no":[30],"published":[31],"reports":[32],"have":[33],"addressed":[34],"use":[36],"consensus":[38],"(CIFN)":[40],"combined":[42,354],"with":[43,148,355],"ribavirin.":[44],"We":[45],"conducted":[46],"a":[47,183,207,325,335,338,375],"pilot":[48],"study":[49,261],"compare":[51],"safety":[53,298],"tolerability":[55,300],"daily":[57,89,310,376],"CIFN":[58,62,81,86,313,350],"plus":[59,90],"monotherapy":[63,160,177,213,249,344],"for":[64,105,158,238,247],"initial":[66],"patients.":[72,329],"Forty":[73],"subjects":[74,98,108,147,174,205,225],"were":[75,137,241,263,306],"randomized":[76],"two":[78,142,278,304],"groups;":[80],"9":[82,87],"microg":[83,88],"daily,":[84],"or":[85,93,185],"1000":[92],"1200":[94],"mg":[95],"daily.":[96],"All":[97],"received":[99,115],"48":[100],"weeks":[101,118],"therapy":[103,163,180,216,323],"except":[104],"nongenotype":[106],"1":[107,150],"in":[109,175,188,211,279,320,324,334,369,374],"group":[113],"who":[114],"only":[116,283],"24":[117],"therapy.":[120],"results":[122],"show":[123],"that":[124,296,309,349],"at":[125,191],"baseline,":[126],"age,":[127],"gender,":[128],"risk":[129],"factors,":[130],"race,":[131],"RNA":[132],"titres,":[133],"liver":[135],"histology":[136],"not":[138,366],"different":[139],"between":[140],"groups.":[143],"proportion":[145,223,327],"genotype":[149],"infection":[151],"50%":[153],"(10/20)":[154,167],"55%":[156,230],"(11/20)":[157,231],"groups,":[164,217,252],"respectively.":[165,235,253,269],"Fifty":[166],"sixty-five":[169],"(13/20)":[170],"per":[171],"cent":[172],"groups":[181],"exhibited":[182,206],"2-log":[184],"greater":[186],"decrease":[187],"viral":[189,209,340],"titre":[190],"week":[192],"12":[193],"(P":[194,219],"=":[195,220],"NS).":[196,221],"Using":[197],"intent-to-treat":[198],"analysis,":[199],"20%":[200,264],"40%":[202],"enrolled":[204],"sustained":[208,361],"response":[210,341,362],"respectively":[218],"requiring":[226],"dose":[227],"reduction":[228],"65%":[233],"(13/20),":[234],"Study":[236],"discontinuations":[237],"any":[239],"reason":[240],"25%":[242,267],"(5/20)":[243],"35%":[245],"(7/20)":[246],"Discontinuations":[254],"due":[255],"adverse":[257,275],"events":[258,276],"related":[259],"drug":[262],"(4/20)":[265],"(5/20),":[268],"A":[270],"total":[271],"four":[273],"serious":[274],"occurred,":[277],"each":[280],"group,":[282],"one":[284],"which":[286],"determined":[288],"study-drug":[291],"related.":[292],"It":[293],"is":[294,365],"concluded":[295],"profiles":[301],"treatments":[305],"similar":[307],"suggesting":[308],"dosing":[311,377],"may":[314,351,358],"difficult":[316],"tolerate":[318],"resulting":[319],"discontinuation":[321],"significant":[326],"regimen":[332],"resulted":[333],"trend":[336],"towards":[337],"higher":[339],"rate":[342,363],"treatment.":[345],"These":[346],"data":[347],"suggest":[348],"safely":[353],"enhance":[359],"but":[364],"well":[367],"tolerated":[368],"US":[370],"given":[373],"regimen.":[378]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}